Michael Brennan to Lactococcus lactis
This is a "connection" page, showing publications Michael Brennan has written about Lactococcus lactis.
Connection Strength
0.120
-
Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer. 2013 Dec 15; 119(24):4268-76.
Score: 0.120